61 related articles for article (PubMed ID: 17043665)
1. DNA methylation-dependent silencing of CST6 in human breast cancer cell lines.
Rivenbark AG; Jones WD; Coleman WB
Lab Invest; 2006 Dec; 86(12):1233-42. PubMed ID: 17043665
[TBL] [Abstract][Full Text] [Related]
2. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q
Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215
[TBL] [Abstract][Full Text] [Related]
3. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S
BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of RNF144A expression in breast cancer cells through promoter hypermethylation and MBD4.
Zhang Y; Yang YL; Zhang FL; Liao XH; Shao ZM; Li DQ
Cancer Med; 2018 Apr; 7(4):1317-1325. PubMed ID: 29473320
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation as a novel regulator of ANO1 expression and function in prostate cancer bone metastasis.
Shin Y; Kim S; An W
Sci Rep; 2024 May; 14(1):11595. PubMed ID: 38773164
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of TNFSF7 (CD70) by DNA methylation during progression to breast cancer.
Yu SE; Park SH; Jang YK
Mol Cells; 2010 Feb; 29(2):217-21. PubMed ID: 20119871
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation biomarker candidates for early detection of colon cancer.
Yi JM; Dhir M; Guzzetta AA; Iacobuzio-Donahue CA; Heo K; Yang KM; Suzuki H; Toyota M; Kim HM; Ahuja N
Tumour Biol; 2012 Apr; 33(2):363-72. PubMed ID: 22238052
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.
Szarc Vel Szic K; Declerck K; Crans RAJ; Diddens J; Scherf DB; Gerhäuser C; Vanden Berghe W
Oncotarget; 2017 Jun; 8(25):40434-40453. PubMed ID: 28467815
[TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin is silenced in malignant mesothelioma by a poly(ADP-ribose) polymerase-1-mediated epigenetic mechanism.
Nocchi L; Tomasetti M; Amati M; Neuzil J; Santarelli L; Saccucci F
J Biol Chem; 2011 Jun; 286(22):19478-88. PubMed ID: 21489980
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the WNT7A gene in clear cell renal cell carcinomas.
Kondratov AG; Kvasha SM; Stoliar LA; Romanenko AM; Zgonnyk YM; Gordiyuk VV; Kashuba EV; Rynditch AV; Zabarovsky ER; Kashuba VI
PLoS One; 2012; 7(10):e47012. PubMed ID: 23056560
[TBL] [Abstract][Full Text] [Related]
11. Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer.
Yang Q; Mori I; Shan L; Nakamura M; Nakamura Y; Utsunomiya H; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Sakurai T; Kakudo K
Am J Pathol; 2001 Jan; 158(1):299-303. PubMed ID: 11141504
[TBL] [Abstract][Full Text] [Related]
12. Silencing of interferon regulatory factor gene 6 in melanoma.
Nobeyama Y; Nakagawa H
PLoS One; 2017; 12(9):e0184444. PubMed ID: 28877249
[TBL] [Abstract][Full Text] [Related]
13. Trans-regulated silencing and reactivation of TP53 tumor suppressor gene in malignant transformation and its reversion.
Yang L; Sasaki MS
Jpn J Cancer Res; 2000 Nov; 91(11):1111-8. PubMed ID: 11092975
[TBL] [Abstract][Full Text] [Related]
14. Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasia.
Triki H; Declerck K; Charfi S; Ben Kridis W; Chaabane K; Ben Halima S; Sellami T; Rebai A; Berghe WV; Cherif B
Cancer Immunol Immunother; 2022 May; 71(5):1139-1155. PubMed ID: 34608548
[TBL] [Abstract][Full Text] [Related]
15. Transcription Silencing and CpGs Hypermethylation as Therapeutic Gene Editing in Clinical Colorectal Adenocarcinoma Repression.
Al-Jumaili MMO
Korean J Gastroenterol; 2024 Jan; 83(1):6-16. PubMed ID: 38268163
[TBL] [Abstract][Full Text] [Related]
16. Deep Sequencing Revealed a CpG Methylation Pattern Associated With
Beniaminov AD; Puzanov GA; Krasnov GS; Kaluzhny DN; Kazubskaya TP; Braga EA; Kudryavtseva AV; Melnikova NV; Dmitriev AA
Front Genet; 2018; 9():169. PubMed ID: 29868117
[TBL] [Abstract][Full Text] [Related]
17. H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island-containing start sites.
Balasubramanian D; Akhtar-Zaidi B; Song L; Bartels CF; Veigl M; Beard L; Myeroff L; Guda K; Lutterbaugh J; Willis J; Crawford GE; Markowitz SD; Scacheri PC
Genome Med; 2012 May; 4(5):47. PubMed ID: 22640407
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation changes in a human cell model of breast cancer progression.
Fernandez SV; Snider KE; Wu YZ; Russo IH; Plass C; Russo J
Mutat Res; 2010 Jun; 688(1-2):28-35. PubMed ID: 20193695
[TBL] [Abstract][Full Text] [Related]
19. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation?
Ohm JE; Baylin SB
Cell Cycle; 2007 May; 6(9):1040-3. PubMed ID: 17457052
[TBL] [Abstract][Full Text] [Related]
20. Predictive Values of Homeobox Gene A-Antisense Transcript 3 (HOXA-AS3), Cystatin 6 (CST6), and Chromobox Homolog 4 (CBX4) Expressions in Cancer Tissues for Recurrence of Early Colon Cancer After Surgery.
Zhu X; Zhao L; Hu P
Int J Gen Med; 2024; 17():1-8. PubMed ID: 38196563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
